Compressed collagen sponges as gastroretentive dosage forms: In vitro and in vivo studies

European Journal of Pharmaceutical Sciences

Volumn 30, Issue 1, 2007, Pages 1-6

  Gröning, Rüdiger ^a   Cloer, Christina ^a   Georgarakis, Manolis ^b   Müller, Rotraut S ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Collagen sponge; Expandable tablets; Gastric residence time; Gastroretentive dosage forms; Riboflavin

Indexed keywords

COLLAGEN SPONGE; DRUG CARRIER; HYDROXYPROPYLMETHYLCELLULOSE; MAGNESIUM STEARATE; RIBOFLAVIN;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER AIDED DESIGN; CONTROLLED CLINICAL TRIAL; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DEVICE; DRUG DEGRADATION; DRUG DOSAGE FORM; DRUG EXCRETION; DRUG MANUFACTURE; DRUG RELEASE; DRUG RETENTION; FEMALE; GASTROINTESTINAL TRACT; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; MALE; MEASUREMENT; NORMAL HUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STOMACH; SUSTAINED DRUG RELEASE; TABLET FORMULATION; TABLET MACHINE; URINARY EXCRETION;

BIOCOMPATIBLE MATERIALS; COLLOIDS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG COMPOUNDING; FEMALE; FREEZE DRYING; HUMANS; MALE; MICROSCOPY, ELECTRON, SCANNING; STOMACH; TABLETS;

EID: 33845429406     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2006.08.003     Document Type: Article

References (29)

1. Abrahamsson B., Alpsten M., Jonsson U.E., Lundberg P.J., Sandberg A., Sundgren M., Svenheden A., and Tolli J. Gastro-intestinal transit of a multiple-unit formulation (metoprolol CR/ZOK) and a non-disintegrating tablet with the emphasis on colon. Int. J. Pharm. 140 (1996) 229-235
2. Cargill R., Caldwell L.J., Engle K., Fix J.A., Porter P.A., and Gardner C.R. Controlled gastric emptying. 1. Effects of physical properties on gastric residence times of nondisintegrating geometric shapes in beagle dogs. Pharm. Res. 5 (1988) 533-536
3. Cargill R., Engle K., Gardner C.R., Porter P.A., Sparer R.V., and Fix J.A. Controlled gastric emptying. II. In vitro erosion and gastric residence times of an erodible device in beagle dogs. Pharm. Res. 6 (1989) 506-509
4. Cedarbaum J.M. Clinical pharmacokinetics of anti-parkinson drugs. Clin. Pharmacokinet. 13 (1987) 141-178
5. Deshpande A.A., Shah N.H., Rhodes C.T., and Malick W. Development of a novel controlled-release system for gastric retention. Pharm. Res. 14 (1997) 815-819
6. Erni W., and Held K. The hydrodynamically balanced system: a novel principle of controlled drug release. Eur. Neurol. 27 (1987) 21-27
7. Forusz H., and Ritschel W.A. The effects of triethanolamine myristate, a fatty acid salt, on the availability of riboflavin in humans. Meth. Find. Exp. Clin. Pharmacol. 19 (1997) 73-76
8. Gröning R. Control of release and biological availability of drugs-investigations into the renal elemination of nitrofurantoin. Int. J. Pharm. 8 (1981) 175-181
9. Gröning R., and Berntgen M. Estimation of the gastric residence time of magnetic dosage forms using the Heidelberg capsule. Pharmazie 51 (1996) 328-331
10. Gröning R., Berntgen M., and Geogorakis M. Acyclovir serum concentrations following peroral administration of magnetic depot tablets and the influence of extracorporal magnets to control gastrointestinal transit. Eur. J. Pharm. Biopharm. 46 (1998) 285-291
11. Gröning R., and Heun G. Oral dosage forms with controlled gastrointestinal transit. Drug Dev. Ind. Pharm. 10 (1984) 527-539
12. Gröning R., and Heun G. Dosage forms with controlled gastrointestinal passage-studies on the adsorption of nitrofurantoin. Int. J. Pharm. 56 (1989) 111-116
13. Gröning R., Werner M., Berntgen M., and Geogorakis M. Peroral controlled release dosage forms with internal magnets and extracorporal magnetic guidance-investigations into the renal elemination of riboflavin. Eur. J. Pharm. Biopharm. 42 (1996) 25-28
14. Hilton A.K., and Deasy P.B. In vitro and in vivo evaluation of an oral sustained-release floating dosage form of amoxycillin trihydrate. Int. J. Pharm. 86 (1992) 79-88
15. Hwang S.J., Park H., and Park K. Gastric retentive drug-delivery systems. Crit. Rev. Ther. Drug Carrier Syst. 15 (1998) 243-284
16. Klausner E.A., Lavy E., Friedman M., and Hoffman A. Expandable gastroretentive dosage forms. J. Control. Rel. 90 (2003) 143-162
17. Klausner E.A., Lavy E., Stepensky D., Friedman M., and Hoffman A. Novel gastroretentive dosage forms: evaluation of gastroretentivity and its effect on riboflavin absorption in dogs. Pharm. Res. 19 (2002) 1516-1523
18. Lee L., Hossain M., Wang Y., and Sedek G. Absorption of rivastigmine from different regions of the gastrointestinal tract in humans. J. Clin. Pharmacol. 44 (2004) 599-604
19. Levy G., and Jusko W. Factors affecting the absorption of riboflavin in man. J. Pharm. Sci. 55 (1966) 285-289
20. Lewis L.D., Fowle A.S.E., Bittiner S.B., Bye A., and Isaacs P.E.T. Human gastrointestinal absorption of acyclovir from tablet, duodenal infusion and sipped solution. Br. J. Clin. Pharmacol. 21 (1986) 459-462
21. Möes A.J. Gastroretentive dosage forms. Crit. Rev. Ther. Drug Carrier Syst. 10 (1993) 143-195
22. Oth M., Franz M., Timmermans J., and Möes A. The bilayer floating capsule: a stomach-directed drug delivery system for misoprostol. Pharm. Res. 9 (1992) 298-302
23. Park H., and Robinson J.R. Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion. Int. J. Pharm. 19 (1984) 107-127
24. Ravichandran P., Shantha K.L., and Rao K.P. Preparation, swelling characteristics and evaluation of hydrogels for stomach specific drug delivery. Int. J. Pharm. 54 (1997) 89-94
25. Santus G., Lazzarini G., Bottoni G., Sandefer E.P., Page R.C., Doll W.J., Ryo U.Y., and Digenis G.A. An in vitro-in vivo investigation of oral bioadhesive controlled furosemide formulation. Eur. J. Pharm. Biopharm. 44 (1997) 39-52
26. Sato Y., Kawashima Y., Takeuchi H., and Yamamoto H. In vivo evaluation of riboflavin-containing microballoons for floating controlled drug delivery system in healthy human volunteers. J. Control. Release 93 (2003) 39-47
27. Staib A.H., Loew D., Harder S., Graul E.H., and Pfab R. Measurement of theophylline absorption from different regions of the gastro-intestinal tract using a remote controlled drug delivery device. Eur. J. Clin. Pharmacol. 30 (1986) 691-697
28. Urquhart, J., 1984. In United States Patent US
29. Vila J.I., Calpena A.C., Obach R., and Domenech J. Gastric, intestinal and colonic absorption of a series of beta-blockers in the rat. Int. J. Clin. Pharmacol. Ther. 30 (1992) 280-286